Hologic

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Hologic and other ETFs, options, and stocks.

About HOLX

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focuses on women’s health and well-being through early detection and treatment. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. 

CEO
Stephen P. MacMillan
CEOStephen P. MacMillan
Employees
7,063
Employees7,063
Headquarters
Marlborough, Massachusetts
HeadquartersMarlborough, Massachusetts
Founded
1985
Founded1985
Employees
7,063
Employees7,063

HOLX Key Statistics

Market cap
15.06B
Market cap15.06B
Price-Earnings ratio
27.94
Price-Earnings ratio27.94
Dividend yield
Dividend yield
Average volume
1.56M
Average volume1.56M
High today
$68.54
High today$68.54
Low today
$67.11
Low today$67.11
Open price
$68.26
Open price$68.26
Volume
1.16M
Volume1.16M
52 Week high
$84.39
52 Week high$84.39
52 Week low
$51.90
52 Week low$51.90

HOLX News

TipRanks 9h
Hologic up 3% at $69.29 following Evercore ISI upgrade

08:15 EDT Hologic (HOLX) up 3% at $69.29 following Evercore ISI upgrade Published first on TheFly – the ultimate source for real-time, market-moving breaking f...

TipRanks 11h
Hologic upgraded to Outperform from In Line at Evercore ISI

Evercore ISI analyst Vijay Kumar upgraded Hologic (HOLX) to Outperform from In Line with a price target of $78, up from $69. Organic revenue is set-up to inflec...

Simply Wall St 2d
Will Dual FDA and CE Approvals for Panther Fusion Shape Hologic's Long-Term Story?

Recently, Hologic, Inc. announced that its Panther Fusion gastrointestinal bacterial and expanded bacterial assays received both FDA 510(k) clearance in the Uni...

Will Dual FDA and CE Approvals for Panther Fusion Shape Hologic's Long-Term Story?

Analyst ratings

55%

of 22 ratings
Buy
40.9%
Hold
54.5%
Sell
4.5%

More HOLX News

TipRanks 5d
Hologic receives FDA clearance for Panther Fusion

Hologic (HOLX) announced that the FDA has granted 510(k) clearance for the Panther Fusion gastrointestinal bacterial and expanded bacterial assays. The company...

People also own

Based on the portfolios of people who own HOLX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.